Condition

Chronic Periodontitis (1)

Coronary Artery Disease (1)

Endodontic Disease (1)

Herpes Simplex Oral (1)

Root Canal Infection (1)

Overall Status

Completed (3)

Enrolling by invitation (1)

Phase

phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Ain Shams University (1)

Dow University of Health Sciences (1)

Mt. Sinai Medical Center, Miami (1)

University of Utah (1)

Collaborator

National Center for Complementary and Integrative Health (NCCIH) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Study Documents

Intervention Type

drug (4)

other (2)

device (1)

dietary supplement (1)

Funder Type

Other (4)

Study Type

Interventional (4)

edta

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Herpes Simplex Oral Trial in Murray (EDTA, Abreva)

Enrolling by invitation

Herpes Simplex Oral

EDTA
Abreva

Murray, Utah

University of Utah MidValley Dermatology

Jan 25, 2022

Endodontic Disease, Root Canal Infection Trial in Karachi (QMix Root Canal Irrigant, 17%EDTA+2%Chlorhexidine, EDTA)

Completed

Endodontic Disease
Root Canal Infection

QMix Root Canal Irrigant
+2 more

Karachi, Sindh, Pakistan

Hasan Zaidi

Feb 22, 2019

Chronic Periodontitis Trial (drug, other, device)

Completed

Chronic Periodontitis

Simvastatin
+3 more

(no location specified)

Feb 5, 2018

Coronary Artery Disease Trial in Canada, United States (EDTA, EDTA Placebo, High Dose Vitamin)

Completed

Has Results

Coronary Artery Disease

EDTA
+3 more

Little Rock, Arkansas
+85 more

Aug 30, 2013